5.75
price down icon2.54%   -0.15
after-market Handel nachbörslich: 5.76 0.010 +0.17%
loading

Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 3.50 -
Operating Expenses
8.49%
14.33
13.21 11.33 14.05 12.04
Interest Income/Expense
773.39%
0.952
0.109 0.105 0.103 0.101
Depreciation and Amortization
0.00%
0.50
0.50 0.50 0.60 0.70
Operating Income/Loss
8.49%
-14.33
-13.21 -11.33 -10.55 -12.04
Nonoperating Income/Loss
24.30%
0.162
0.214 0.111 2.215 0.403
Income/Loss From Continuing Operations Before Tax
176.84%
-31.58
41.10 -11.84 3.50 -9.107
Income/Loss From Continuing Operations After Tax
90.33%
-31.58
-16.59 -11.84 -16.65 -9.107
Net Income/Loss
90.33%
-31.58
-16.59 -11.84 -16.65 -9.107
Preferred Stock Dividends And Other Adjustments
0.022
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,800%
27.32
1.4379 24.80 18.02 16.90
Diluted Average Shares
1,800%
27.32
1.4379 24.80 18.02 -0.5538
Basic Earnings Per Share
81.25%
-1.16
-0.64 -0.48 0.92 -0.54
Diluted Earnings Per Share
81.25%
-1.16
-0.64 -0.48 0.92 0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.022
- - - -
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):